10 FDA panel doctors with financial ties to Abbott approved the TriClip heart device, raising transparency and impartiality concerns.
10 FDA panel doctors reviewing Abbott's heart device had financial ties with the company, receiving $650k in payments from 2016-2022. Despite this, the FDA approved the TriClip device, raising questions about transparency and the impartiality of committee members. The FDA's Open Payments database records various industry payments, including research funding and general payments.
April 08, 2024
5 Articles